Pulmonx CorporationLUNGNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-2.82%
↓ 117% below average
Average (6y)
16.78%
Historical baseline
Range
High:75.11%
Low:-13.47%
Volatility
528.0%
High variability
| Period | Value |
|---|---|
| 2024 | -2.82% |
| 2023 | 17.43% |
| 2022 | 17.87% |
| 2021 | 75.11% |
| 2020 | 23.33% |
| 2019 | -13.47% |
| 2018 | 0.00% |